ID   ULK1_HUMAN              Reviewed;        1050 AA.
AC   O75385; Q9UQ28;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   02-NOV-2010, entry version 97.
DE   RecName: Full=Serine/threonine-protein kinase ULK1;
DE            EC=2.7.11.1;
DE   AltName: Full=Unc-51-like kinase 1;
GN   Name=ULK1; Synonyms=KIAA0722;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=98360094; PubMed=9693035; DOI=10.1006/geno.1998.5340;
RA   Kuroyanagi H., Yan J., Seki N., Yamanouchi Y., Suzuki Y., Takano T.,
RA   Muramatsu M., Shirasawa T.;
RT   "Human ULK1, a novel serine/threonine kinase related to UNC-51 kinase
RT   of Caenorhabditis elegans: cDNA cloning, expression, and chromosomal
RT   assignment.";
RL   Genomics 51:76-85(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=99087487; PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   MEDLINE=22158633; PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-816.
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   INTERACTION WITH GABARAP AND GABARAPL2.
RX   MEDLINE=21066693; PubMed=11146101; DOI=10.1016/S0169-328X(00)00218-7;
RA   Okazaki N., Yan J., Yuasa S., Ueno T., Kominami E., Masuho Y.,
RA   Koga H., Muramatsu M.-A.;
RT   "Interaction of the Unc-51-like kinase and microtubule-associated
RT   protein light chain 3 related proteins in the brain: possible role of
RT   vesicular transport in axonal elongation.";
RL   Brain Res. Mol. Brain Res. 85:1-12(2000).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-556, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-638, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-638, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-450; SER-477 AND
RP   SER-479, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-450; THR-456 AND
RP   SER-556, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-717, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   SUBUNIT.
RX   PubMed=19597335;
RA   Hosokawa N., Sasaki T., Iemura S.I., Natsume T., Hara T.,
RA   Mizushima N.;
RT   "Atg101, a novel mammalian autophagy protein interacting with Atg13.";
RL   Autophagy 5:1-7(2009).
RN   [13]
RP   SUBUNIT, AND INTERACTION WITH RPTOR AND TORC1 COMPLEX.
RX   PubMed=19211835; DOI=10.1091/mbc.E08-12-1248;
RA   Hosokawa N., Hara T., Kaizuka T., Kishi C., Takamura A., Miura Y.,
RA   Iemura S., Natsume T., Takehana K., Yamada N., Guan J.L., Oshiro N.,
RA   Mizushima N.;
RT   "Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200
RT   complex required for autophagy.";
RL   Mol. Biol. Cell 20:1981-1991(2009).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH ATG13.
RX   PubMed=18936157; DOI=10.1128/MCB.01082-08;
RA   Chan E.Y.W., Longatti A., McKnight N.C., Tooze S.A.;
RT   "Kinase-inactivated ULK proteins inhibit autophagy via their conserved
RT   C-terminal domains using an Atg13-independent mechanism.";
RL   Mol. Cell. Biol. 29:157-171(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-450, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-450; SER-469; SER-623;
RP   SER-638 AND SER-758, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-290; LEU-298; LEU-478; MET-503;
RP   LEU-665; LEU-714 AND CYS-784.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Involved in autophagy. Required for autophagosome
CC       formation (By similarity). Target of the TOR kinase signaling
CC       pathway that regulates autophagy through the control of
CC       phosphorylation status of ATG13/KIAA0652 and ULK1, and the
CC       regulation of the ATG13-ULK1-RB1CC1 complex (By similarity).
CC       Phosphorylates ATG13/KIAA0652. Involved in axon growth (By
CC       similarity). Plays an essential role in neurite extension of
CC       cerebellar granule cells (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with GABARAP and GABARAPL2. Interacts (via C-
CC       terminus) with ATG13/KIAA0652. Part of a complex consisting of
CC       ATG13/KIAA0652, ULK1 and RB1CC1. Associates with the mammalian
CC       target of rapamycin complex 1 (mTORC1) through an interaction with
CC       RPTOR; the association depends on nutrient conditions and is
CC       reduced during starvation.
CC   -!- INTERACTION:
CC       O95166:GABARAP; NbExp=1; IntAct=EBI-908831, EBI-712001;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol (By similarity).
CC       Preautophagosomal structure (By similarity). Note=Under starvation
CC       conditions, is localized to puncate structures primarily
CC       representing the isolation membrane that sequesters a portion of
CC       the cytoplasm resulting in the formation of an autophagosome (By
CC       similarity).
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Detected in the
CC       following adult tissues: skeletal muscle, heart, pancreas, brain,
CC       placenta, liver, kidney, and lung.
CC   -!- PTM: Phosphorylated under nutrient-rich conditions;
CC       dephosphorylated during starvation or following treatment with
CC       rapamycin (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. APG1/unc-51/ULK1 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA34442.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF045458; AAC32326.1; -; mRNA.
DR   EMBL; AB018265; BAA34442.2; ALT_INIT; mRNA.
DR   EMBL; AC131009; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   IPI; IPI00289357; -.
DR   RefSeq; NP_003556.1; -.
DR   UniGene; Hs.47061; -.
DR   ProteinModelPortal; O75385; -.
DR   SMR; O75385; 16-286.
DR   IntAct; O75385; 4.
DR   MINT; MINT-1892187; -.
DR   STRING; O75385; -.
DR   PhosphoSite; O75385; -.
DR   PRIDE; O75385; -.
DR   Ensembl; ENST00000321867; ENSP00000324560; ENSG00000177169.
DR   GeneID; 8408; -.
DR   KEGG; hsa:8408; -.
DR   UCSC; uc001uje.1; human.
DR   CTD; 8408; -.
DR   GeneCards; GC12P132379; -.
DR   H-InvDB; HIX0019606; -.
DR   HGNC; HGNC:12558; ULK1.
DR   MIM; 603168; gene.
DR   PharmGKB; PA37198; -.
DR   eggNOG; prNOG07636; -.
DR   HOGENOM; HBG446996; -.
DR   HOVERGEN; HBG000342; -.
DR   InParanoid; O75385; -.
DR   PhylomeDB; O75385; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 31476; -.
DR   ArrayExpress; O75385; -.
DR   Bgee; O75385; -.
DR   CleanEx; HS_ULK1; -.
DR   Genevestigator; O75385; -.
DR   GermOnline; ENSG00000177169; Homo sapiens.
DR   GO; GO:0005776; C:autophagic vacuole; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0000407; C:pre-autophagosomal structure; IEA:UniProtKB-SubCell.
DR   GO; GO:0070969; C:ULK1-ATG13-FIP200 complex; IPI:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0032403; F:protein complex binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; NAS:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0008104; P:protein localization; IMP:UniProtKB.
DR   GO; GO:0010506; P:regulation of autophagy; IMP:UniProtKB.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR022708; Ser/Thr_kinase_C.
DR   InterPro; IPR016237; Ser/Thr_prot_kin_STPK_Ulk-1/2.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR013336; Ser/Thr_prot_kinase_Unc-51/Ulk.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF38; Ser/Thr_prot_kinase_Unc-51; 1.
DR   Pfam; PF12063; DUF3543; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF000580; Ser/Thr_PK_STPK_ULK-1/2; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Autophagy; Complete proteome; Cytoplasm; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1050       Serine/threonine-protein kinase ULK1.
FT                                /FTId=PRO_0000086780.
FT   DOMAIN       16    278       Protein kinase.
FT   NP_BIND      22     30       ATP (By similarity).
FT   REGION      287    416       Interaction with GABARAP and GABARAPL2.
FT   COMPBIAS    297    310       Poly-Ser.
FT   ACT_SITE    138    138       Proton acceptor (By similarity).
FT   BINDING      46     46       ATP (By similarity).
FT   MOD_RES     450    450       Phosphoserine.
FT   MOD_RES     456    456       Phosphothreonine.
FT   MOD_RES     469    469       Phosphoserine.
FT   MOD_RES     477    477       Phosphoserine.
FT   MOD_RES     479    479       Phosphoserine.
FT   MOD_RES     556    556       Phosphoserine.
FT   MOD_RES     623    623       Phosphoserine.
FT   MOD_RES     625    625       Phosphothreonine (By similarity).
FT   MOD_RES     638    638       Phosphoserine.
FT   MOD_RES     717    717       Phosphothreonine.
FT   MOD_RES     758    758       Phosphoserine.
FT   VARIANT     290    290       V -> M (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041274.
FT   VARIANT     298    298       S -> L (in dbSNP:rs56364352).
FT                                /FTId=VAR_041275.
FT   VARIANT     478    478       P -> L (in dbSNP:rs12827141).
FT                                /FTId=VAR_041276.
FT   VARIANT     503    503       T -> M (in dbSNP:rs55824543).
FT                                /FTId=VAR_041277.
FT   VARIANT     665    665       S -> L (in dbSNP:rs55815560).
FT                                /FTId=VAR_041278.
FT   VARIANT     714    714       P -> L (in dbSNP:rs11546871).
FT                                /FTId=VAR_041279.
FT   VARIANT     784    784       S -> C (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041280.
FT   VARIANT     816    816       A -> T (in dbSNP:rs11609348).
FT                                /FTId=VAR_054892.
SQ   SEQUENCE   1050 AA;  112601 MW;  4ED9B94028E3C138 CRC64;
     MEPGRGGTET VGKFEFSRKD LIGHGAFAVV FKGRHREKHD LEVAVKCINK KNLAKSQTLL
     GKEIKILKEL KHENIVALYD FQEMANSVYL VMEYCNGGDL ADYLHAMRTL SEDTIRLFLQ
     QIAGAMRLLH SKGIIHRDLK PQNILLSNPA GRRANPNSIR VKIADFGFAR YLQSNMMAAT
     LCGSPMYMAP EVIMSQHYDG KADLWSIGTI VYQCLTGKAP FQASSPQDLR LFYEKNKTLV
     PTIPRETSAP LRQLLLALLQ RNHKDRMDFD EFFHHPFLDA SPSVRKSPPV PVPSYPSSGS
     GSSSSSSSTS HLASPPSLGE MQQLQKTLAS PADTAGFLHS SRDSGGSKDS SCDTDDFVMV
     PAQFPGDLVA EAPSAKPPPD SLMCSGSSLV ASAGLESHGR TPSPSPPCSS SPSPSGRAGP
     FSSSRCGASV PIPVPTQVQN YQRIERNLQS PTQFQTPRSS AIRRSGSTSP LGFARASPSP
     PAHAEHGGVL ARKMSLGGGR PYTPSPQVGT IPERPGWSGT PSPQGAEMRG GRSPRPGSSA
     PEHSPRTSGL GCRLHSAPNL SDLHVVRPKL PKPPTDPLGA VFSPPQASPP QPSHGLQSCR
     NLRGSPKLPD FLQRNPLPPI LGSPTKAVPS FDFPKTPSSQ NLLALLARQG VVMTPPRNRT
     LPDLSEVGPF HGQPLGPGLR PGEDPKGPFG RSFSTSRLTD LLLKAAFGTQ APDPGSTESL
     QEKPMEIAPS AGFGGSLHPG ARAGGTSSPS PVVFTVGSPP SGSTPPQGPR TRMFSAGPTG
     SASSSARHLV PGPCSEAPAP ELPAPGHGCS FADPIAANLE GAVTFEAPDL PEETLMEQEH
     TEILRGLRFT LLFVQHVLEI AALKGSASEA AGGPEYQLQE SVVADQISLL SREWGFAEQL
     VLYLKVAELL SSGLQSAIDQ IRAGKLCLSS TVKQVVRRLN ELYKASVVSC QGLSLRLQRF
     FLDKQRLLDR IHSITAERLI FSHAVQMVQS AALDEMFQHR EGCVPRYHKA LLLLEGLQHM
     LSDQADIENV TKCKLCIERR LSALLTGICA
//
